In Vivo Occupancy of Dopamine D3 Receptors by Antagonists Produces Neurochemical and Behavioral Effects of Potential Relevance to Attention-Deficit–Hyperactivity Disorder

@article{Barth2013InVO,
  title={In Vivo Occupancy of Dopamine D3 Receptors by Antagonists Produces Neurochemical and Behavioral Effects of Potential Relevance to Attention-Deficit–Hyperactivity Disorder},
  author={Vanessa N. Barth and Anne B. Need and Eleni T. Tzavara and Bruno Giros and Carl D. Overshiner and Scott D. Gleason and Mark R. Wade and Anette M. Johansson and Kenneth W. Perry and G. Nomikos and Jeffrey M. Witkin},
  journal={The Journal of Pharmacology and Experimental Therapeutics},
  year={2013},
  volume={344},
  pages={501 - 510}
}
  • V. Barth, A. Need, +8 authors J. Witkin
  • Published 1 February 2013
  • Biology, Psychology, Chemistry
  • The Journal of Pharmacology and Experimental Therapeutics
Dopamine D3 receptors have eluded definitive linkage to neurologic and psychiatric disorders since their cloning over 20 years ago. We report a new method that does not employ a radiolabel for simultaneously defining in vivo receptor occupancy of D3 and D2 receptors in rat brain after systemic dosing using the tracer epidepride (N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-5-iodo-2,3-dimethoxybenzamide). Decreases in epidepride binding in lobule 9 of cerebellum (rich in D3 receptors) were compared… 
The Role of Dopamine D3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens
TLDR
The results suggested D3 receptor partial agonist activity of cariprazine, producing functional antagonism, may contribute to its efficacy in schizophrenia and bipolar disorder.
Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D2 and D3 Receptors
TLDR
D-301 has greater intrinsic efficacy to activate D3 receptors than D-264, whereas the two compounds act on D2 receptors with similar intrinsic efficacy, which suggest caution in interpreting Emax values from functional assays in receptor-transfected cell models without accounting for receptor reserve.
What is the role of the D3 receptor in addiction? A mini review of PET studies with [11C]-(+)-PHNO
Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders
TLDR
An overview and update of the major aspects of research related to D3Rs: distribution in the CNS and periphery, signaling and molecular properties, the status of ligands available for D3R research (agonists, antagonists and partial agonists), behavioral functions of D2Rs, the role in neural networks, and a summary on how the D2R-related drug research has been translated to human therapy are provided.
The role of dopamine D3 receptors in the mechanism of action of cariprazine
TLDR
The reviewed results support the potential benefits of cariprazine in treating negative symptoms and cognitive deficits of schizophrenia, and therefore representing a promising approach in addressing the unmet clinical needs for the improved treatment of this serious neuropsychiatric disorder.
Imaging Alcohol Induced Dopamine Release in the Human Brain: a PET/[11C]-(+)-PHNO Study
TLDR
The alcohol-induced dopaminergic response in social drinkers using [C]-(+)-PHNO is explored, suggesting that this response may be heterogeneous and the various factors influencing this response warrant further investigation.
...
1
2
3
...

References

SHOWING 1-10 OF 77 REFERENCES
Dopamine Agonist-Induced Yawning in Rats: A Dopamine D3 Receptor-Mediated Behavior
TLDR
It is reported that dopamine D2/D3 agonists elicit dose-dependent yawning behavior in rats, resulting in an inverted U-shaped dose-response curve.
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A.
TLDR
The effect of SB-277011-A on isolation-induced prepulse inhibition deficit suggests that blockade of dopamine D(3) receptors may benefit the treatment of schizophrenia.
Selective dopamine D3 receptor antagonists: a review 2001-2005.
TLDR
The preclinical findings that selective antagonism at DA D(3) receptors reduces the reinforcing efficacy of drugs of abuse, reverses cognitive deficits, and shows efficacy in animal models of schizophrenia add to an accumulating body of evidence that selective DA D-3 receptor antagonists may hold highest promise in the treatment of several neuropsychiatric diseases.
Two Novel and Selective Nonimidazole H3 Receptor Antagonists A-304121 and A-317920: II. In Vivo Behavioral and Neurophysiological Characterization
  • G. Fox, J. Pan, +9 authors A. Hancock
  • Biology, Chemistry
    Journal of Pharmacology and Experimental Therapeutics
  • 2003
TLDR
A-304121 and A-317920 represent a series of novel, H3R-selective piperazine amides that enhance cognition in vivo, which could offer advantages over existing H3 R antagonists or cognition-enhancing agents.
Protection against Cocaine Toxicity in Mice by the Dopamine D3/D2 Agonist R-(+)-trans-3,4a,10b-Tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907]
TLDR
Findings suggest that the prevention of cocaine convulsions and lethality by (+)-PD 128,907 may be due to D3 receptor-mediated events.
Selective Antagonism at Dopamine D3 Receptors Enhances Monoaminergic and Cholinergic Neurotransmission in the Rat Anterior Cingulate Cortex
TLDR
Assessment of the effects of the acute systemic administration of the selective DA D3 receptor antagonist SB-277011-A on the in vivo extracellular levels of monoamines and acetylcholine in the anterior cingulate subregion of the medial prefrontal cortex provides evidence of the important role ofDA D3 receptors in the effect of pharmacotherapeutic agents used for the treatment of psychiatric disorders such as schizophrenia and drug dependence.
A functional test identifies dopamine agonists selective for D3 versus D2 receptors.
TLDR
The known behavioural actions of D3 selective agonists support a role for the D3 receptor in motor inhibitions, which should be taken into account for the treatment of motor dysfunctions by dopamine agonists.
Stereoselective binding of 11C-raclopride in living human brain — a search for extrastriatal central D2-dopamine receptors by PET
The selective D2-dopamine receptor antagonist raclopride and its pharmacologically inactive (R)-enantiomer FLB472 were labelled with 11C and used in a study with positron emission tomography to
...
1
2
3
4
5
...